You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for Patent: 6,753,013


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,753,013
Title: Pharmaceutical composition
Abstract:A pharmaceutical composition for dermal use, wherein the composition has a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue, and a second pharmacologically active component B consisting of at least one corticosteroid, wherein the difference between the maximum stability pH of said first component A and the maximum stability pH of said second component B is at least 1. The composition can also have at least one solvent component C, where component C is compounds of the general formula R.sup.3 (OCH.sub.2 C(R.sup.1)H).sub.x OR.sup.2 (I), wherein x is in the range of 2-60, R.sup.1 in each of the x units independently is H or CH.sub.3, R.sup.2 is straight chain or branched C.sub.1-20 alkyl or benzoyl, and R.sup.3 is H or phenylcarbonyloxy; di-(straight or branched)-C.sub.4-10 alkyl esters of C.sub.4 -C.sub.8 dicarboxylic acids; straight or branched C.sub.12-18 -alkyl benzoates; straight or branched C.sub.2-4 -alkyl esters of straight or branched C.sub.10-18 -alkanoic or -alkenoic acids; propylenglycol diesters with C.sub.8-14 -alkanoic acids; and branched primary C.sub.18-24 alkanols.
Inventor(s): Didriksen; Erik (Ballerup, DK), H.o slashed.y; Gert (Ballerup, DK)
Assignee: Leo Pharmaceutical Products, Ltd. A/S (Ballerup, DK)
Application Number:09/959,367
Patent Claim Types:
see list of patent claims
Composition; Compound; Use; Dosage form;

Drugs Protected by US Patent 6,753,013

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,753,013

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark1999 00561Apr 23, 1999
PCT Information
PCT FiledJanuary 27, 2000PCT Application Number:PCT/DK00/00033
PCT Publication Date:November 02, 2000PCT Publication Number: WO00/64450

International Family Members for US Patent 6,753,013

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2278300 ⤷  Try a Trial
Australia 774600 ⤷  Try a Trial
Bulgaria 106030 ⤷  Try a Trial
Bulgaria 65115 ⤷  Try a Trial
Brazil 0009956 ⤷  Try a Trial
Canada 2370565 ⤷  Try a Trial
China 1173703 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.